In this study, we designed two recombinant influenza vaccines based on the recombinant proteins encoding HA1 of a H5N1 virus fused to either Fc of pFUSE-hIgG1-Fc2 (human IgG Fc, thereafter named Fc) or Fd plus Fc. Here, ELP1 is linked to influenza.